Table 5.

Factors associated with LTFU among the intervention and comparison group participants

Factor	Intervention				Comparison group
	Univariate HR (95% CI)	p value	Multivariate HR (95% CI)	p value	Univariate HR (95% CI)	p value	Multivariate HR (95% CI)	p value1
CD4		0.01		0.12		<0.001		<0.0001
<200	0.75 (0.54, 0.03)		1.55 (1.11, 2.15)		3.20 (2.52, 4.53)		2.13 (1.63, 2.75)
200 to <350	0.31 (0.21, 0.45)		0.86 (0.58, 1.27)		2.52 (1.98, 3.21)		1.83 (1.41, 2.36)
350+	Reference		Reference		Reference		Reference
Weight WT		0.83		0.65		0.001		0.0200
<45	0.98 (0.99, 1.02)		0.29 (0.02, 0.32)		0.96 (0.68, 1.36)		1.48 (0.95, 2.31)
45–60	Reference		Reference		Reference		Reference
60+	0.94 (0.97, 2.03)		0.34 (0.03, 2.01)		1.60 (1.31, 1.96)		2.01 (1.63, 2.49)
HBG		0.74		0.09		<0.001		<0.000
<8.5	1.11 (0.60, 2.07)		1.93 (0.91, 3.67)		0.40 (0.38, 0.43)		3.24 (2.97, 3.55)	1
8.5 to <10	0.68 (0.47, 0.99)		0.10 (0.06,0.16)		0.44 (0.42, 0.46)		0.48 (0.46, 0.51)
10 to <12	1.91 (1.32, 2.77)		1.17 (1.11, 0.26)		0.57 (0.55, 0.60)		1.00 (0.95, 1.05)
12+	Reference		Reference		Reference		Reference
ART duration		<0.0001		<0.0001		<0.0001		<0.001
<12	Reference		Reference		Reference		Reference
12+	0.39 (0.27–0.57)		0.42 (0.28–0.63)		2.34 (1.98–0.21)		2.51 (1.84–0.43)
Gender						<0.000		0.0400
Male	0.02 (0.01–10.47)	0.85			1.49 (1.22–0.82)	1	1.28 (1.01–0.63)
Female	Reference				Reference
Age		0.89				0.002		0.0300
<30	3.31 (0.01–0.67)				0.87 (0.64–0.99)		0.73 (0.54–0.99)
30 to <40	3.23 (0.01–0.23)				0.92 (0.79–0.15)		0.89 (0.69–0.14)
40 to <50	Reference				Reference		Reference
50+	5.21 (0.02–0.23)				0.24 (0.06–0.38)		0.14 (0.06–0.35)

¹p value was obtained from Chi square test